A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Shanghai Simnova Biotechnology Co.,Ltd.
Sichuan University
Oncotherapeutics
Zhongnan Hospital
Qilu Pharmaceutical Co., Ltd.
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Chongqing Precision Biotech Co., Ltd
Peking University People's Hospital
Zhejiang University
Celularity Incorporated
Second Affiliated Hospital, School of Medicine, Zhejiang University
Nanjing IASO Biotechnology Co., Ltd.
Sorrento Therapeutics, Inc.
Tongji Hospital
Institute of Hematology & Blood Diseases Hospital, China
Gadeta B.V.
Shanghai Changzheng Hospital
Zhejiang University
Keymed Biosciences Co.Ltd
Shanghai Changzheng Hospital
Hrain Biotechnology Co., Ltd.
Karolinska University Hospital
First Affiliated Hospital of Zhejiang University
Peking Union Medical College Hospital
Shanghai Tongji Hospital, Tongji University School of Medicine
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chong Kun Dang Pharmaceutical
Chong Kun Dang Pharmaceutical
University of Leeds
Shanghai Theorion Pharmaceutical Co Ltd.
The First Affiliated Hospital with Nanjing Medical University
Hebei Yanda Ludaopei Hospital
Second Affiliated Hospital of Xi'an Jiaotong University
Second Affiliated Hospital of Xi'an Jiaotong University
Shenzhen Second People's Hospital
National University of Ireland, Galway, Ireland
Shenzhen Second People's Hospital
Benovus Bio, Inc.
Wuhan University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Peter MacCallum Cancer Centre, Australia
Cylene Pharmaceuticals
Cylene Pharmaceuticals
Icahn School of Medicine at Mount Sinai
Immune Control